TWI255717B - Botulinum toxin implant - Google Patents

Botulinum toxin implant

Info

Publication number
TWI255717B
TWI255717B TW90112092A TW90112092A TWI255717B TW I255717 B TWI255717 B TW I255717B TW 90112092 A TW90112092 A TW 90112092A TW 90112092 A TW90112092 A TW 90112092A TW I255717 B TWI255717 B TW I255717B
Authority
TW
Taiwan
Prior art keywords
botulinum toxin
toxin implant
controlled release
release system
implant
Prior art date
Application number
TW90112092A
Other languages
Chinese (zh)
Inventor
Stephen Donovan
Original Assignee
Allergan Sales Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/624,003 external-priority patent/US6312708B1/en
Application filed by Allergan Sales Llc filed Critical Allergan Sales Llc
Application granted granted Critical
Publication of TWI255717B publication Critical patent/TWI255717B/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A controlled release system for multiphasic, in vivo release of therapeutic amounts of botulinum toxin in a human patient over a prolonged period of time. The controlled release system can comprise a plurality of botulinum toxin incorporating polymeric microspheres.
TW90112092A 2000-07-21 2001-05-21 Botulinum toxin implant TWI255717B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/624,003 US6312708B1 (en) 2000-06-02 2000-07-21 Botulinum toxin implant

Publications (1)

Publication Number Publication Date
TWI255717B true TWI255717B (en) 2006-06-01

Family

ID=37515586

Family Applications (1)

Application Number Title Priority Date Filing Date
TW90112092A TWI255717B (en) 2000-07-21 2001-05-21 Botulinum toxin implant

Country Status (2)

Country Link
AR (1) AR028670A1 (en)
TW (1) TWI255717B (en)

Also Published As

Publication number Publication date
AR028670A1 (en) 2003-05-21

Similar Documents

Publication Publication Date Title
WO2001093890A3 (en) Botulinum toxin implant
WO2005011769A3 (en) Implantable or insertable medical devices containing acrylic copolymer for controlled delivery of therapeutic agent
WO2004010975A3 (en) Controlled drug delivery
IL161746A0 (en) Closed automated system for tissue based therapy, dosing and administration using same
AU2002351207A8 (en) Emergency call and patient locating system for implanted automatic defibrillators
AU1453602A (en) Systems, devices and methods for suturing patient tissue
EP1143935A3 (en) Controlled-release biocompatible ocular drug delivery implant devices and methods
AU2001255846A8 (en) Dental implant system
AU5478601A (en) Medical implant
AU2001254786A1 (en) Medical implant
WO2002067895A3 (en) Implant dosage form and use thereof for the delivery of a cholesterol lowering agent
AU2546401A (en) Dental prosthesis with means for the release of active substances
AU2003223480A1 (en) Medical devices adapted for controlled in vivo structural change after implantation
WO1999004772A3 (en) Use of levobupivacaine
GB9926231D0 (en) Medical implants
IL135947A0 (en) Human blood bacterium
ZA200201819B (en) Preventive and therapeutic agents for eye diseases.
NZ513650A (en) Pharmaceutical composition for the treatment of urinary incontinence, motion sickness and vertigo
HK1047707A1 (en) Use of (+)-tramadol, o-demethyltramadol or (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol or (+)-o-desmethyl-n-mono-desmethyl-tramadol for treating urinary incontinence
AU2001294861A1 (en) Resorbable prosthesis for medical treatment
TWI255717B (en) Botulinum toxin implant
AU5340801A (en) Therapeutic compounds and methods
WO2001089558A3 (en) Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
HK1038515A1 (en) Controlled delivery of antidepressants
WO2001028539A3 (en) Agent for treating cephalic pain

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees